glycyrrhizic acid has been researched along with nsc 4347 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Faizah, O; Farihah, HS; Nazrun, SA; Nirwana, SI; Norazlina, M; Norliza, M; Suhana, MR | 1 |
Elvy Suhana, MR; Fairus, A; Farihah, HS; Ima Nirwana, S; Santhana, R; Tan, MH | 1 |
2 other study(ies) available for glycyrrhizic acid and nsc 4347
Article | Year |
---|---|
Piper sarmentosum prevents glucocorticoid-induced osteoporotic bone resorption by increasing 11β-hydroxysteroid dehydrogenase type 1 activity.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adrenalectomy; Animals; Biomarkers; Bone Resorption; Corticosterone; Dexamethasone; Drug Evaluation, Preclinical; Enzyme Induction; Femur; Glucocorticoids; Glycyrrhizic Acid; Male; Osteoblasts; Osteoclasts; Osteoporosis; Phytotherapy; Piper; Plant Extracts; Rats; Rats, Sprague-Dawley | 2011 |
Piper sarmentosum is comparable to glycyrrhizic acid in reducing visceral fat deposition in adrenalectomised rats given dexamethasone.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adrenalectomy; Animals; Anti-Obesity Agents; Disease Models, Animal; Glycyrrhizic Acid; Intra-Abdominal Fat; Male; Obesity; Phytotherapy; Piper; Plant Extracts; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2013 |